Effects of prebiotics on gut health in ulcerative colitis
Official title: The Clinical and Microbial Impact of Prebiotics in Ulcerative Colitis
Run by University of California, Los Angeles · NCT06495658 · Data updated 2026-11-12
This study is testing if taking prebiotics can improve gut health in people with ulcerative colitis who have active symptoms.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | University of California, Los Angeles Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Status | Recruiting |
| Started | July 9, 2024 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2027 |
| Registry record updated | February 27, 2026 |
| Trial ID | NCT06495658 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 to 85 with a history of biopsy-proven ulcerative colitis and active symptoms.
✕Probably not a fit
Patients who have undergone prior colectomy or have unstable major medical conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the impact of prebiotic supplementation on gut microbiome composition and overall gut health in patients with ulcerative colitis. Participants aged 18 to 85 with active symptoms will be randomized to receive prebiotics for either 8 weeks starting at week 0 or week 8. Dietary composition will be assessed at baseline and throughout the 16-week period, with stool samples collected for analysis of microbial changes. The goal is to understand how dietary interventions can influence IBD outcomes.
Why it matters
Potential benefit: If successful, this study could provide new dietary strategies to improve gut health and manage symptoms in patients with ulcerative colitis.
How similar studies have gone: Previous studies have indicated that dietary interventions can positively affect gut microbiome composition, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Ages 18 to 85 years old * History of biopsy-proven ulcerative colitis (UC) * Active symptoms (SCCAI \>2) * Concomitant use of 5-aminosalicylates, immunomodulators, and corticosteroids will be permitted, although initiation or dose adjustment must not have occurred within 30 days prior to enrollment. * Concomitant use of biologic therapy will be permitted, although initiation or dose adjustment must not have occurred within 60 days prior to enrollment. * Prior probiotics or other dietary supplements use is permitted but will be asked to be discontinued during the course of the trial Exclusion Criteria: * Prior colectomy * Hospitalization * Urgent need for abdominal surgery * Unstable major medical condition * Active malignancy under treatment * Active alcohol or non-cannabinoid substance abuse * Pregnancy or lactation * Concerns for non-compliance
Where it's running
-
UCLA
Los Angeles, California, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
A Probiotic Approach to Modulating Gut Microbiota in Mild-to-Moderate Ulcerative Colitis
A specific probiotic given rectally will be tested in adults with mild-to-moderate ulcerative colitis to see if it can help manage symptoms.
-
Self-management program to improve health in inflammatory bowel disease
A digital self-management program is being tested to see if it helps people with inflammatory bowel disease feel better and manage their symptoms alongside standard care.
-
Cardiovascular risk in people with Crohn's disease and ulcerative colitis
This study tests whether people with inflammatory bowel disease have different heart-attack or stroke risk over two years compared with matched controls.
-
Observational study comparing inflammatory markers in IBD and non-IBD participants
This study is trying to see how inflammation levels in people with Crohn's Disease and Ulcerative Colitis compare to those without these conditions when they start new treatments.
-
Evaluating robotic surgery for inflammatory bowel disease
This study is testing if robotic surgery can be a good option for adults with inflammatory bowel disease, like Crohn's or ulcerative colitis, compared to traditional surgery methods.
-
How nutrition and body composition relate to outcomes in people with IBD
This study will see if nutrition and muscle mass affect outcomes in people with Crohn's disease or ulcerative colitis who are starting advanced medicines or having IBD-related surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.